Status:
UNKNOWN
Pediatric ANCA Associated-vasculitis
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
ANCA-Associated Vasculitis
Eligibility:
All Genders
1-17 years
Brief Summary
The incidence in pediatrics is very low (about 0.5 per million according to a French study) and therefore the data on the pathology very poor, especially on the therapeutic level. Without appropriate...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Minor subject (\<18 years old)
- Diagnosis of ANCA vasculitis according to the international criteria for defining the pathology, GPA or MPA form between 2011 and 2020.
- Subject (and/or his parental authority) who has not expressed, after being informed, his opposition to the reuse of his data for the purposes of this research.
- Exclusion criteria:
- Subject (or his parents) having expressed his (their) opposition to participating in the study
- Patients with vasculitis has ANCA in the form of EGPA
- Associated pathologies that cannot be related to the diagnosis of ANCA vasculitis and whose prognosis can lead to biases in the efficacy and/or complications related to treatments.
Exclusion
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05383573
Start Date
January 1 2022
End Date
December 31 2022
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, France, 67091